WallStreetZenWallStreetZen

NYSEMKT: CATX
Perspective Therapeutics Inc Stock Ownership - Who owns Perspective Therapeutics?

Insider buying vs selling

Have Perspective Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark John AustinVP FinancePrin FinAcct Offic2024-04-2330,000$0.36
$10.80kBuy
Lantheus Alpha Therapy LLC10% Owner2024-03-0660,431,039$0.95
$57.41MBuy
Robert F. Williamson IiiDirector2024-01-305,127$0.71
$3.64kBuy
Robert F. Williamson IiiDirector2024-01-3042,879$0.72
$30.87kBuy
Robert F. Williamson IiiDirector2024-01-303,500$0.70
$2.45kBuy
Robert F. Williamson IiiDirector2024-01-3057,121$0.71
$40.56kBuy
Robert F. Williamson IiiDirector2024-01-3018,579$0.71
$13.19kBuy
Robert F. Williamson IiiDirector2024-01-294,031$0.64
$2.58kBuy
Robert F. Williamson IiiDirector2024-01-2921,235$0.64
$13.59kBuy
Robert F. Williamson IiiDirector2024-01-2625,000$0.55
$13.75kBuy

1 of 3

CATX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CATX insiders and whales buy or sell their stock.

CATX Shareholders

What type of owners hold Perspective Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Lantheus Alpha Therapy LLC19.90%116,773,394$198.51MInsider
Vanguard Group Inc2.25%13,213,750$22.46MInstitution
Baker Bros Advisors LP1.30%7,639,703$12.99MInstitution
Blackrock Inc0.77%4,538,389$7.72MInstitution
Geode Capital Management LLC0.43%2,516,649$4.28MInstitution
Ghost Tree Capital LLC0.27%1,600,000$2.72MInstitution
Osterweis Capital Management Inc0.27%1,582,100$2.69MInstitution
Lori A. Woods0.27%1,567,814$2.67MInsider
Markus Puhlmann0.23%1,375,425$2.34MInsider
Hightower Advisors LLC0.23%1,332,238$2.26MInstitution

1 of 3

CATX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CATX6.23%20.98%Net BuyingNet Buying
AVNS95.04%2.94%Net BuyingNet Buying
AORT76.80%23.20%Net SellingNet Selling
FNA17.89%82.11%Net SellingNet Buying
CTKB60.34%21.49%Net SellingNet Selling

Perspective Therapeutics Stock Ownership FAQ

Who owns Perspective Therapeutics?

Perspective Therapeutics (NYSEMKT: CATX) is owned by 6.23% institutional shareholders, 20.98% Perspective Therapeutics insiders, and 72.79% retail investors. Lantheus Alpha Therapy LLC is the largest individual Perspective Therapeutics shareholder, owning 116.77M shares representing 19.90% of the company. Lantheus Alpha Therapy LLC's Perspective Therapeutics shares are currently valued at $197.35M.

If you're new to stock investing, here's how to buy Perspective Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.